Sulfated endospermic nanocellulose crystals prevent the transmission of SARS-CoV-2 and HIV-1

被引:0
|
作者
Enrique Javier Carvajal-Barriga
Wendy Fitzgerald
Emilios K. Dimitriadis
Leonid Margolis
R. Douglas Fields
机构
[1] National Institutes of Health,Nervous System Development and Plasticity Section, Eunice Kennedy Shriver National Institute of Child Health and Human Development
[2] Pontificia Universidad Católica del Ecuador,Neotropical Center for the Biomass Research
[3] National Institutes of Health,Section On Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development
[4] National Institutes of Health,Biomedical Engineering and Physical Science Shared Resource Program, National Institute of Biomedical Imaging and Bioengineering
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Biomaterials with antimicrobial activity are gaining attention due to their biodegradability and efficacy in interacting with a wide range of microorganisms. A new cellulose nano-biomaterial, endospermic nanocellulose crystals (ENC) obtained from parenchymal tissue of ivory nut endosperm, has a natural capacity as a universal binder. This feature is enhanced when it is chemically functionalized, and can be exploited in the fight against microbes. We tested the ability of sulfated ENC in aqueous suspension to encapsulate viruses through a crosslinking reaction mediated by cations. 0.25% w/v ENC suspensions efficiently encapsulated spike (S) protein, preventing its interaction with ACE2 receptor. ENC was further able to encapsulate SARS-CoV-2 pseudoviruses and prevent infection of 293T-hsACE2 cells. ENC also suppressed infection of MT-4 cells with HIV-1LAI.04. This antiviral activity of sulfated ENC is due to the irreversible interaction of ENC with viral particles mediated by crosslinking, as antiviral activity was less effective in the absence of cations. Additionally, ENC was used as a matrix to immobilize recombinant ACE2 receptors and anti-S IgG, creating molecular lures that efficiently inhibited SARS-CoV-2 infections in vitro. These results show that sulfated ENC from ivory nuts can be used as an efficient antiviral material.
引用
收藏
相关论文
共 50 条
  • [11] Intracerebral Plasmacytoma in a Patient with HIV-1 Infection and SARS-CoV-2 Superinfection
    Nazarovs, Jurijs
    Lapse, Daira
    Sture, Gunta
    Soloveicika, Marina
    Jaunozolina, Liga
    Ozolina, Elina
    Lejniece, Sandra
    BRAIN SCIENCES, 2022, 12 (06)
  • [12] Transmission of SARS-CoV-2
    Bikbov, Boris
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (07) : 1036 - 1037
  • [13] Darunavir does not prevent SARS-CoV-2 infection in HIV patients
    Riva, Agostino
    Conti, Federico
    Bernacchia, Dario
    Pezzati, Laura
    Sollima, Salvatore
    Merli, Stefania
    Siano, Matteo
    Lupo, Angelica
    Rusconi, Stefano
    Cattaneo, Dario
    Gervasoni, Cristina
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [14] SARS-CoV-2 and HIV
    Joob, Beuy
    Wiwanitkit, Viroj
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1415 - 1415
  • [15] Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review
    Naidoo, Nitalia
    Moodley, Jagidesa
    Khaliq, Olive Pearl
    Naicker, Thajasvarie
    VIRUS RESEARCH, 2022, 319
  • [16] Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2
    Ocampo, Ferron F.
    Promsena, Pathariya
    Chan, Phillip
    CURRENT HIV/AIDS REPORTS, 2023, 20 (06) : 345 - 356
  • [17] Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2
    Scoca, Viviana
    Di Nunzio, Francesca
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2021, 13 (04) : 259 - 268
  • [18] Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2
    McCormick, Kevin D.
    Mellors, John W.
    Jacobs, Jana L.
    CURRENT OPINION IN HIV AND AIDS, 2021, 16 (01) : 3 - 10
  • [19] Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2
    Ferron F. Ocampo
    Pathariya Promsena
    Phillip Chan
    Current HIV/AIDS Reports, 2023, 20 : 345 - 356
  • [20] Repurposing SARS-CoV-2 Main Protease Inhibitors for HIV-1 Protease Inhibition
    Minkkinen, Jacob P.
    Gentile, Lisa
    FASEB JOURNAL, 2022, 36